Cronos Group Inc
thecronosgroup.comWhat Do They Do?
Sells cannabis flower, pre-rolls and edibles to adult-use and medical customers through provincial cannabis authorities, retailers and distributors.
10-K for FY2025, filed Feb 26, 2026In Canada, Cronos sells a variety of cannabis products through wholesale channels including under our Spinach®, PEACE NATURALS® and Lord…View ↗
Adult-Use. Cronos currently sells dried flower, pre-rolls, vaporizers, concentrates and edibles through its brands, Spinach® and Lord…View ↗
Israel. Cronos Israel distributes PEACE NATURALS® and LIT™ branded cannabis products to the Israeli medical market through pharmacies. In…View ↗
In Canada, Cronos sells cannabis products to cannabis control authorities in all provinces of Canada and the Yukon territory, except for…View ↗
How Do They Make Money?
Customers buy cannabis flower, extracts and other cannabinoid products; sales are counted when products ship or are delivered, or when a customer uses consigned products. Payment terms vary by customer and product.
10-K for FY2025, filed Feb 26, 2026Revenue is measured based on the consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a…View ↗
The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is…View ↗
Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in…View ↗
-
10-K for FY2025, filed Feb 26, 2026
FY2025 revenue by product or service ↗
$146.6M
-
10-K for FY2025, filed Feb 26, 2026
$146.6M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Cannabis flower
Sold outright
10-K for FY2025, filed Feb 26, 2026 |
74%
FY2022: 73%
|
Cannabis flower, FY2025
$108.5M Sources
|
Sold outright |
|
Cannabis extracts
Sold outright
10-K for FY2025, filed Feb 26, 2026 |
26%
FY2022: 26%
|
Cannabis extracts, FY2025
$37.7M Sources
|
Sold outright |
|
Other
|
0.3%
FY2022: 0.7%
|
Other, FY2025
$411K Sources
|
Who Are Their Customers?
In Canada, adult-use cannabis is sold wholesale to provincial cannabis authorities, except in Saskatchewan where it goes directly to private retailers; medical products reach users through distributors. In Israel, products go through pharmacies, and other international markets are served by third-party distributors.
10-K for FY2025, filed Feb 26, 2026Adult-Use. Cronos currently sells dried flower, pre-rolls, vaporizers, concentrates and edibles through its brands, Spinach® and Lord…View ↗
Israel. Cronos Israel distributes PEACE NATURALS® and LIT™ branded cannabis products to the Israeli medical market through pharmacies. In…View ↗
Additionally, Cronos GrowCo sells products in the wholesale channel into the markets listed above as well as Canada and select other…View ↗
In Canada, Cronos sells cannabis products to cannabis control authorities in all provinces of Canada and the Yukon territory, except for…View ↗
Do Revenues Turn Into Profits?
Not on paper. It lost $9.4M in FY2025, but brought in more cash than it spent: $149K of free cash flow.
10-K for FY2025, filed Feb 26, 2026
−$17.4MView ↗
10-K for FY2025, filed Feb 26, 2026
−$9.4MView ↗
10-K for FY2025, filed Feb 26, 2026
$149KView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 6, 2026
$32.1MView ↗
- ▲ Now profitable
- vs −$39.7M in Q2 FY2025
10-Q for Q2 FY2026, filed Aug 6, 2026
Open tableView ↗
-
Sep 8, 2026
Cronos extended the deadline for its planned CanAdelaar acquisition
The long-stop date moved from September 9, 2026 to October 15, 2026.
Sources
8-K, filed Sep 11, 2026
The Second SPA Amendment extends the Long Stop Date (as defined in the SPA) from September 9, 2026 to October 15, 2026.View ↗
Growing. Revenue grew 2.3x in 4 years, from $64.6M in FY2021 to $146.6M in FY2025, about 23% a year.
LIT medical brand
Adds LIT as an international medical brand: the older report described a portfolio of Spinach, PEACE NATURALS and Lord Jones, while the latest lists LIT among its brands and describes its medical-market sales.
10-K for FY2022, filed Feb 28, 2023 10-K for FY2025, filed Feb 26, 2026Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research…View ↗
Fermentation exit
Exited fermentation-based cannabinoid manufacturing and stopped operating facilities using the Ginkgo collaboration intellectual property; the older report described a licensed facility for producing cultured cannabinoids.
10-K for FY2022, filed Feb 28, 2023 10-K for FY2025, filed Feb 26, 2026Ginkgo paid Cronos nominal consideration for the termination of the licenses to the Ginkgo intellectual property and the collaboration…View ↗
Loading...
